These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 17696572)
1. Neurogenic actions of atypical antipsychotic drugs and therapeutic implications. Newton SS; Duman RS CNS Drugs; 2007; 21(9):715-25. PubMed ID: 17696572 [TBL] [Abstract][Full Text] [Related]
2. Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT(1A) receptor activation. Schreiber R; Newman-Tancredi A Neurobiol Learn Mem; 2014 Apr; 110():72-80. PubMed ID: 24423786 [TBL] [Abstract][Full Text] [Related]
3. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Dazzan P; Morgan KD; Orr K; Hutchinson G; Chitnis X; Suckling J; Fearon P; McGuire PK; Mallett RM; Jones PB; Leff J; Murray RM Neuropsychopharmacology; 2005 Apr; 30(4):765-74. PubMed ID: 15702141 [TBL] [Abstract][Full Text] [Related]
4. Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis. Jann MW Pharmacotherapy; 2004 Dec; 24(12):1759-83. PubMed ID: 15585443 [TBL] [Abstract][Full Text] [Related]
5. RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia. Rajagopal L; Kwon S; Huang M; Michael E; Bhat L; Cantillon M; Meltzer HY Behav Brain Res; 2017 Aug; 332():180-199. PubMed ID: 28373127 [TBL] [Abstract][Full Text] [Related]
6. Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment. Emsley R; Asmal L; du Plessis S; Chiliza B; Phahladira L; Kilian S Psychol Med; 2017 Sep; 47(12):2187-2196. PubMed ID: 28347393 [TBL] [Abstract][Full Text] [Related]
7. Comparison of cognitive performances during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds. Weickert TW; Goldberg TE; Marenco S; Bigelow LB; Egan MF; Weinberger DR Neuropsychopharmacology; 2003 Aug; 28(8):1491-500. PubMed ID: 12799617 [TBL] [Abstract][Full Text] [Related]
8. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Navari S; Dazzan P Psychol Med; 2009 Nov; 39(11):1763-77. PubMed ID: 19338710 [TBL] [Abstract][Full Text] [Related]
9. The modulation of adult neuroplasticity is involved in the mood-improving actions of atypical antipsychotics in an animal model of depression. Morais M; Patrício P; Mateus-Pinheiro A; Alves ND; Machado-Santos AR; Correia JS; Pereira J; Pinto L; Sousa N; Bessa JM Transl Psychiatry; 2017 Jun; 7(6):e1146. PubMed ID: 28585931 [TBL] [Abstract][Full Text] [Related]
10. Improvement of prefrontal brain function in endogenous psychoses under atypical antipsychotic treatment. Ehlis AC; Herrmann MJ; Pauli P; Stoeber G; Pfuhlmann B; Fallgatter AJ Neuropsychopharmacology; 2007 Aug; 32(8):1669-77. PubMed ID: 17203015 [TBL] [Abstract][Full Text] [Related]
11. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia. Lesh TA; Tanase C; Geib BR; Niendam TA; Yoon JH; Minzenberg MJ; Ragland JD; Solomon M; Carter CS JAMA Psychiatry; 2015 Mar; 72(3):226-34. PubMed ID: 25588194 [TBL] [Abstract][Full Text] [Related]
12. Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder. Elie D; Poirier M; Chianetta J; Durand M; Grégoire C; Grignon S J Psychopharmacol; 2010 Jul; 24(7):1037-44. PubMed ID: 19164494 [TBL] [Abstract][Full Text] [Related]
13. Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients. Beninger RJ; Baker TW; Florczynski MM; Banasikowski TJ Neurotox Res; 2010 Nov; 18(3-4):229-43. PubMed ID: 20376711 [TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
15. Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol. Gomes FV; Llorente R; Del Bel EA; Viveros MP; López-Gallardo M; Guimarães FS Schizophr Res; 2015 May; 164(1-3):155-63. PubMed ID: 25680767 [TBL] [Abstract][Full Text] [Related]